v3.26.1
Condensed Consolidated Statements of Changes in Shareholders' Deficit (Unaudited) - USD ($)
Total
Ordinary Shares
Class A
Ordinary Shares
Class B
Additional Paid-in Capital
Accumulated Deficit
Beginning Balance at Nov. 26, 2024      
Beginning Balance (in Shares) at Nov. 26, 2024      
Class B Ordinary Shares issued to Sponsor (in Shares)   5,750,000    
Class B Ordinary Shares issued to Sponsor $ 25,000   $ 575 $ 24,425  
Net loss (18,571)     $ (18,571)
Ending Balance at Dec. 31, 2024 6,429 $ 575 24,425 (18,571)
Ending Balance (in Shares) at Dec. 31, 2024   5,750,000    
Sale of Private Placement Warrants 4,500,000 4,500,000
Fair Value of Public Warrants at issuance 2,185,000 2,185,000
Allocated value of transaction costs to Class A Ordinary Shares (84,264) (84,264)
Accretion for Class A Ordinary Shares to redemption amount (11,691,817) (6,625,161) (5,066,656)
Net loss (6,303,763) (6,303,763)
Ending Balance at Mar. 31, 2025 (11,388,415) $ 575 (11,388,990)
Ending Balance (in Shares) at Mar. 31, 2025   5,750,000    
Beginning Balance at Dec. 31, 2024 6,429 $ 575 24,425 (18,571)
Beginning Balance (in Shares) at Dec. 31, 2024   5,750,000    
Sale of Private Placement Warrants 4,500,000   4,500,000  
Fair Value of Public Warrants at issuance 2,185,000   2,185,000  
Allocated value of transaction costs to Class A Ordinary Shares (84,264) (84,264)  
Accretion for Class A Ordinary Shares to redemption amount (18,866,179) (6,625,161) (12,241,018)
Net loss (16,495,381)     (16,495,381)
Ending Balance at Dec. 31, 2025 (28,754,395) $ 575 (28,754,970)
Ending Balance (in Shares) at Dec. 31, 2025   5,750,000    
Accretion for Class A Ordinary Shares to redemption amount (2,101,884) (2,101,884)
Net loss (129,303) (129,303)
Ending Balance at Mar. 31, 2026 $ (30,985,582) $ 575 $ (30,986,157)
Ending Balance (in Shares) at Mar. 31, 2026   5,750,000